替加环素：用于治疗多重微生物感染的单一抗生素。 - Suppr

Suppr

超能文献

Tigecycline: a single antibiotic for polymicrobial infections.

作者信息

Pankey George A, Steele Russell W

机构信息

Department of Infectious Diseases, Ochsner Clinic Foundation, New Orleans, LA, USA.

出版信息

Pediatr Infect Dis J. 2007 Jan;26(1):77-8. doi: 10.1097/01.inf.0000253038.78188.26.

DOI:10.1097/01.inf.0000253038.78188.26

PMID:17195711

Abstract

摘要

相似文献

Tigecycline: a single antibiotic for polymicrobial infections.

Pediatr Infect Dis J. 2007 Jan;26(1):77-8. doi: 10.1097/01.inf.0000253038.78188.26.

[Tigecycline, the first of a new class of antibiotics: the glycylcyclines].

Rev Esp Quimioter. 2007 Mar;20(1):19-35.

Tigecycline: a review of a new glycylcycline antibiotic.

J Dermatolog Treat. 2005;16(4):207-12. doi: 10.1080/09546630510011810.

Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):163-4. doi: 10.1016/j.diagmicrobio.2005.06.011.

More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.

J Antimicrob Chemother. 2012 Apr;67(4):1048-9. doi: 10.1093/jac/dkr556. Epub 2011 Dec 29.

Tigecycline pharmacokinetic/pharmacodynamic update.

J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i11-6. doi: 10.1093/jac/dkn242.

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.

Int J Antimicrob Agents. 2009 Jul;34(1):101-2. doi: 10.1016/j.ijantimicag.2009.01.015. Epub 2009 Mar 10.

Establishing the role of tigecycline in an era of antimicrobial resistance.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):557-67. doi: 10.1586/14787210.6.5.557.

Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary.

J Chemother. 2005 Aug;17 Suppl 1:3-4. doi: 10.1179/joc.2005.17.Supplement-1.3.

Tigecycline: place in therapy and important considerations.

Am J Health Syst Pharm. 2006 Jul 1;63(13):1233. doi: 10.2146/ajhp060206.

引用本文的文献

Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant with multi-route tigecycline: A case report.

World J Clin Cases. 2021 Jan 26;9(3):651-658. doi: 10.12998/wjcc.v9.i3.651.

Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.

Purulent pericarditis with quadruple valve endocarditis.

Am J Case Rep. 2015 Apr 23;16:236-9. doi: 10.12659/AJCR.893072.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Tigecycline: a single antibiotic for polymicrobial infections.

Pediatr Infect Dis J. 2007 Jan;26(1):77-8. doi: 10.1097/01.inf.0000253038.78188.26.

[Tigecycline, the first of a new class of antibiotics: the glycylcyclines].

Rev Esp Quimioter. 2007 Mar;20(1):19-35.

Tigecycline: a review of a new glycylcycline antibiotic.

J Dermatolog Treat. 2005;16(4):207-12. doi: 10.1080/09546630510011810.

Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):163-4. doi: 10.1016/j.diagmicrobio.2005.06.011.

More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.

J Antimicrob Chemother. 2012 Apr;67(4):1048-9. doi: 10.1093/jac/dkr556. Epub 2011 Dec 29.

Tigecycline pharmacokinetic/pharmacodynamic update.

J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i11-6. doi: 10.1093/jac/dkn242.

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.

Int J Antimicrob Agents. 2009 Jul;34(1):101-2. doi: 10.1016/j.ijantimicag.2009.01.015. Epub 2009 Mar 10.

Establishing the role of tigecycline in an era of antimicrobial resistance.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):557-67. doi: 10.1586/14787210.6.5.557.

Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary.

J Chemother. 2005 Aug;17 Suppl 1:3-4. doi: 10.1179/joc.2005.17.Supplement-1.3.

Tigecycline: place in therapy and important considerations.

Am J Health Syst Pharm. 2006 Jul 1;63(13):1233. doi: 10.2146/ajhp060206.

引用本文的文献

Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant with multi-route tigecycline: A case report.

World J Clin Cases. 2021 Jan 26;9(3):651-658. doi: 10.12998/wjcc.v9.i3.651.

Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.

Purulent pericarditis with quadruple valve endocarditis.

Am J Case Rep. 2015 Apr 23;16:236-9. doi: 10.12659/AJCR.893072.